Morphic Therapeutic (MORF) announced that Simon Cooper, M.B.B.S., has joined the Company as Chief Medical Officer. Dr. Cooper most recently served as Chief Medical Officer of Keros Therapeutics (KROS).
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on MORF:
- Morphic Holding Unveils Updated Corporate Presentation
- Morphic price target lowered to $66 from $68 at Canaccord
- Morphic to Participate in March Investor Conferences
- Morphic price target lowered to $64 from $67 at Wells Fargo
- Morphic Announces Corporate Highlights and Financial Results for the Full Year 2023